Produkty 1881277-32-2

CAS 1881277-32-2 występuje w naszej ofercie pod nazwami: Resolvin D1–d5, Resolvin D1-d5, 99.2%. Oferty producentów: GLPBio, MedChemExpress. Dostępne opakowania: 10μg, 25μg, 25 μg (262.11 µM * 250 μL in Ethanol), 10 μg (262.11 µM * 100 μL in Ethanol).

Resolvin D1–d5
GLPBio
  • opakowanie: 10μg, 25μg
  • Warianty: 2
od 1523,78
Zobacz produkt
Resolvin D1-d5, 99.2%
MedChemExpress
  • opakowanie: 25 μg (262.11 µM * 250 μL in Ethanol), 10 μg (262.11 µM * 100 μL in Ethanol)
  • Warianty: 2
od 2265,53
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(4Z,7S,8R,9E,11E,13Z,15E,17S,19Z)-21,21,22,22,22-pentadeuterio-7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid (CAS 1881277-32-2) to związek chemiczny o wzorze sumarycznym C22H32O5 i masie molowej 381.5 g/mol. Nazwa systematyczna IUPAC: (4Z,7S,8R,9E,11E,13Z,15E,17S,19Z)-21,21,22,22,22-pentadeuterio-7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid. InChIKey: OIWTWACQMDFHJG-CLQVKFETSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H32O5
Masa molowa381.5 g/mol
Nazwa IUPAC(4Z,7S,8R,9E,11E,13Z,15E,17S,19Z)-21,21,22,22,22-pentadeuterio-7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid
InChIKeyOIWTWACQMDFHJG-CLQVKFETSA-N
SMILES[2H]C([2H])([2H])C([2H])([2H])/C=C\C[C@@H](\C=C\C=C/C=C/C=C/[C@H]([C@H](C/C=C\CCC(=O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Resolvin D1-d5, 7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-21,21',22,22,22-d5docosahexaenoicacid, RvD1-d5, D5-RvD1
Powiązane formy tego związku
(4Z,7S,8R,9E,11E,13Z,15E,17R,19Z)-7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid C22H32O5
7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid C22H32O5
Izomery (ten sam wzór sumaryczny)
(4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)-7,16,17-trihydroxydocosa-4,8,10,12,14,19-hexaenoic acid C22H32O5
(6S,8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C22H32O5
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C22H32O5
(6S,8S,9S,10R,11S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-11,17-dihydroxy-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C22H32O5
3,5,6-trihydroxy-4,6-bis(3-methylbut-2-enyl)-2-(4-methylpentanoyl)cyclohexa-2,4-dien-1-one C22H32O5
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(1,2-dihydroxyethyl)-11,17-dihydroxy-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C22H32O5
[(1S,2R,4aS,8aS)-1-[2-(furan-3-yl)ethyl]-1-hydroxy-2,5,5,8a-tetramethyl-3-oxo-4a,6,7,8-tetrahydro-4H-naphthalen-2-yl] acetate C22H32O5
15-acetyloxy-11-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid C22H32O5
[(2S)-4-[(1S,2S)-2-[3-(furan-3-yl)propanoyl]-2,6,6-trimethylcyclohexyl]-3-oxobutan-2-yl] acetate C22H32O5
(4S,5R,6E,8E,10Z,13Z,15E,17S,19Z)-4,5,17-trihydroxydocosa-6,8,10,13,15,19-hexaenoic acid C22H32O5